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The mechanism of action of desferrioxamine in the inhibition of the catalysis of iron-induced oxidative damage has been ascribed to its ability 
to chelate available ferric ion (&= 1Cri). However, recent work has proposed that the trihydroxamate moiety of desferrioxamine can also be in- 
volved in electron transfer reactions involving the superoxide radical, peroxidase/hydrogen peroxide mixtures and ferry1 myoglobin radicals. In 
this study we report evidence for the ability of desferrioxamine to inhibit peroxidative damage to pathological membranes with which non-haem 
iron is associated through a mechanism of action as a lipid chain breaking antioxidant, independently of its iron chelating properties. 
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1. INTRODUCTION 
Desferrioxamine is currently the only iron chelator in 
widespread clinical use to treat states of iron overload. 
It chelates available ferric iron [l] rendering it unable to 
participate in redox cycling and thereby catalyse poten- 
tially damaging redox reactions. Iron within haem is 
not chelatable. 
Abnormal iron-containing species have been describ- 
ed both within the intact sickle erythocyte and asso- 
ciated with the isolated membrane [2-91, the majority 
of the latter being mainly non-haem in nature [8,9]. 
Studies in vitro have suggested that such iron species 
may contribute towards the amplification and propaga- 
tion of peroxidative damage to lipids in sickle cell mem- 
branes by catalysing the breakdown of lipid hydro- 
peroxides, these responses being suppressed on incor- 
poration of antioxidants uch as tocopherol[4]. Desfer- 
rioxamine has also been reported to suppress the incu- 
bation-induced exacerbation of lipid peroxidation in 
sickle cell membranes [4]. This observation was inter- 
preted as an indication of the availability of chelatable 
iron in the sickle cell membrane and its involvement in 
the mechanism of the peroxidative degradation of the 
membrane lipids. 
Recent work has proposed that the trihydroxamate 
moiety of desferrioxamine, the centre involved in the 
binding of the iron, can be involved in electron transfer 
through its ability to donate atoms or electrons to 
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horseradish peroxidase/hydrogen peroxide mixtures 
[lo, 1 l] and to ferry1 myoglobin [l l-131 and to interact 
with superoxide radicals [14]. The oxidation of 
oxyhaemoglobin [ 15,161 and oxyleghaemoglobin [171 
by desferrioxamine has also been documented. 
Here we report findings consistent with the ability of 
desferrioxamine to act as a chain-breaking antioxidant 
of peroxidising lipids in biological membranes in- 
dependently of its iron chelating properties. The results 
provide evidence for the formation of the desferriox- 
amine nitroxide radical suggesting that the iron- 
mediated propagation of lipid peroxidation may be in- 
hibited in sickle erythrocyte membranes by a mecha- 
nism of hydrogen donation from the trihydroxamate 
centre. 
2. MATERIALS AND METHODS 
All reagents were obtained from Sigma unless otherwise stated. 
Desferrioxamine was used as the mesylate derivative (Desferal, Ciba- 
Geigy). Horse spleen ferritin in isotonic saline was dialysed extensive- 
ly against conalbumin (50 mg/ml) before use [18]. 
Erythrocyte membranes were prepared from sickle and normal 
erythrocytes by the method of Dodge et al. [19] at pH 7.4 and not 
subsequently resealed. Membranes were quantified on the basis of 
protein content using the method of Lowry et al. [20] with bovine 
serum albumin as a standard. 
Membrane-associated non-haem iron was assayed utilising a 
modification of the ferrozine assay [21] at pH 7.4 in 10 mM 
phosphate-buffered saline with sodium dodecyl sulphate (0.67% w/v) 
to solubilise membranes. The absorbance at 562 nm was monitored as 
a function of time. The reaction between ferrozine and membrane- 
associated non-haem iron was complete after 48 h. Concentrations of 
non-haem iron were calculated by use of standard curves prepared us- 
ing ferrous sulphate or ferric chloride in 10 mM hydrochloric acid. 
Equivalent results were obtained making use of the molar extinction 
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coefficient for the ferrozine:iron complex of 2.79x 104 at 562 nm 
[22]. The response of ferritin in this assay was also examined. 
The ability of membrane-associated iron components to catalyse 
the breakdown of organic hydroperoxides to alkoxyl and peroxyl 
radical species was assessed using electron spin resonance spec- 
troscopy applying the spin trap 5,5-dimethyl-l-pyrroline-N-oxide 
(DMPO). Sickle and normal erythrocyte membranes (1.7 mg pro- 
tein/ml) were incubated at 22°C with t-butyl hydroperoxide (10 mM) 
and DMPO (40 mM) in an aqueous ample cell within the cavity of a 
Bruker ESP 300 electron spin resonance spectrometer equipped with 
100 kHz modulation and a Brucker ER035M gaussmeter for field 
calibration. Hyperfine coupling constants were measured directly 
from the field scan and compared with previously reported values 
[23]. Spectra were recorded 90 s after mixing and, where necessary, 
scanned repeatedly with 10 s intervals. Spin adduct concentrations 
were obtained by measuring the peak to peak line heights of signals 
recorded at identical times after initiation of the reaction using iden- 
tical machine settings. 
Ferritin, at concentrations corresponding to the levels of non-haem 
iron species associated with sickle membranes, was examined in this 
system after extensive dialysis against EDTA. 
3. RESULTS AND DISCUSSION 
To elucidate the catalytic properties of iron-con- 
taining components associated with the sickle ery- 
throcyte membrane electron spin resonance spectro- 
scopy was applied using the spin trap DMPO. The abili- 
ty of the membrane-bound iron complexes retained by 
sickle erythrocyte membranes to initiate the breakdown 
of a model hydroperoxide, t-butyl hydroperoxide, to 
alkoxyl and peroxyl radical species was assessed: typical 
ESR spectra of alkoxyl-DMPO and peroxyl-DMPO 
radical adducts are shown in Fig. 1. Significantly higher 
concentrations of the alkoxyl and peroxyl radical spin 
adducts were produced by sickle erythrocyte mem- 
branes compared to normal membranes (Table I). 
The levels and availability for reaction at physio- 
logical pH of non-haem iron species associated with 
sickle membranes were assessed as described in section 
2. One component of this iron reacted within 60 min in 
this assay. This available component was present at 
levels of 6.1 f 4 nmol iron/mg membrane protein 
(n = 13 patients) which represents 46 + 11% (n = 13) of 
the total non-haem iron associated with the erythrocyte 
membranes of this group of patients. The remainder of 
the iron species was unavailable to ferrozine within a 
realistic time scale. Non-haem iron was not detected in 
normal membrane preparations. 
Investigations were undertaken to correlate the extent 
of the hydroperoxide breakdown, in terms of peroxyl 
radical generation, with the levels of non-haem iron 
associated with erythrocyte membranes from different 
sickle patients. The initial rate of peroxyl radical spin 
adduct generation from hydroperoxide catalysed by 
sickle erythrocyte membranes correlated (r = 0.95) 
(Fig. 2) with the levels of the more available component 
of the iron component. 
The presence of a more available and less available 
component of non-haem iron associated with sickle 
erythrocyte membranes is consistent with earlier reports 
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Fig. 1. ESR spectra observed on reaction of erythrocyte membranes 
with t-BuOOH in the presence of the spin trap DMPO. Spectra of in- 
cubations (22”C, air-saturated, pH 7.4) containing sickle cell 
erythrocyte membranes (A) or normal erythrocyte membranes (B), 10 
mM t-BuOOH and 40 mM DMPO were recorded 90 s after mixing. 
Spectra assigned to a mixture of the peroxyl (0) and alkoxyl (A) 
radical adducts to DMPO by comparison of hyperfine coupling con- 
stants with previously reported data [23]. 
[8,9] in which it has been suggested that the less 
available component may represent iron within ferritin. 
In the present studies, ferritin released iron very slowly 
in the non-haem iron assay, comparably with the less 
available component of non-haem iron associated with 
sickle erythrocyte membranes, whereas ferrous and fer- 
ric iron salts reacted to completion within 1 min. Fer- 
ritin, at suitable concentrations, admixed with normal 
membranes or alone demonstrated no detectable 
catalytic activity on t-butyl hydroperoxide, as expected, 
when examined by ESR spectroscopy. 
The effects of desferrioxamine on the production of 
alkoxyl and peroxyl radicals in this system were studied 
by preincubating sickle or normal erythrocyte mem- 
branes with desferrioxamine (90 /cM) for 1 h at 22°C 
before the addition of t-butyl hydroperoxide (10 mM) 
and DMPO (40 mM). This treatment significantly 
reduced the levels of alkoxyl and peroxyl radical spin 
adducts (Table I) and in addition signals from the 
Table I 
Radical generation from hydroperoxide catalysed by membrane- 
associated iron-species and the effect of desferrioxamine (DFO) 
Peroxyl radical adduct signal (peak height in 





Sickle erythrocyte Normal erythrocyte 
membranes membranes 
7.93 f 1.6* 4.11 * 1.3 
5.79 f 1.3t 5.02 f 1.7 
Sickle and normal membranes were added to t-butyl hydroperoxide 
and the radical generation after 150 s was assessed by electron spin 
resonance spectroscopy using the spin trap DMPO. Identical mem- 
brane aliquots were pretreated with desferrioxamine before examina- 
tion in the same way. Values are given as peak-to-peak line heights of 
the peroxyl radical adduct in mm obtained using identical machine 
conditions, after division by the protein concentration of the mem- 
brane preparation in mg/ml. Values are mean f SD for 5 determina- 
tions. 
* Different from normal membranes (P<O.Ol, two sample t-test) 
t Different from untreated sickle membranes (P<O.Ol, paired r-test) 
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Fig. 2. Available nouhaem iron-species associated with the sickle 
branes (q average of 5 ~~ations~ is shown for ~rn~~~n~ 
membrane and generation of radical species from hydroperoxide. The 
levels of non-haem iron reacting within 60 min in the ferrozine assay 
are shown for sickle erythrocyte membranes from different patients 
and correlated with the radical generation induced by these mem- 
branes as measured by electron spin resonaace spectroscopy (A, 
peroxyl radical adduct measured after I50 s; see text). Radical genera- 
tiou from hy~o~o~de in the same system induced by normal mem- 
desferrioxamine nitroxide radical [ 141 were also 
detected (Fig. 3) These responses were more extensive 
at higher desferrioxamine concentrations, with greater 
suppression of the signals ~rrespo~di~g to alkoxyl and 
pcroxyg radical adducts such that at 10 n&4 the sign&s 
were almost com~let~y dim&rated and greatly increas- 
ed concentrations of desferrioxamine radicals were 
observed. Tn similar experiments incorporating ferriox- 
amine (the iron complex of desferrioxamine) no nitrox- 
ide signals were &served. No DMPO adducts to the 
hydroxyl radical were observed in these experiments. 
When normal erythrocyte membranes were similarly 
~re~ncn~ted with desfe~~oxa~ne at co~c~ntra~o~ of
10 mM or greater, the levels of the alkoxy[ and peroxyl 
DMPO radical adducts were diminished and the desfer- 
rioxamine nitroxide radical was observed. Lower con- 
centrations of desferrioxamine (90 flM) were ineffec- 
tive. Breakdown of hydroperoxides by normal ery- 
throcyte membranes is attributable to the low levels of 
associated haem iron. Similar results were obtained 
from e~rime~ts carried ant to assess the scaveng~g 
of alkoxyf and peroxyl radicals by desf~~~ox~ine in a 
model system utilising &butyI hydroperoxide and 
methaemoglobin in the absence of non-haem iron (data 
not shown). 
Apart from its capacity to chelate ferric iron, desfer- 
rioxamine can be oxidised by the superoxide radical 
$341, has been reported to act as an electron donor to 
the ferry1 rnyo~ob~~ radical fK& and has recently been 
shown to scavenge the peroxyl radical in suspensions of 
linoleic acid in which oxidation has been initiated by a 
thermolabile azo compound [24]. In this study desfer- 
rioxamine has been shown to decrease the intensity of 
the observed alkoxyl and peroxyl DMPO radical ad- 
ducts generated by endugenous iron complexes 
1,mT 
. . .r * . . . * * 
Pi& 3. ~ko~~-DMP~ and broil-Dab radical adduct signals as 
detected by ESR produced by the reaction of sickle erythrocyte mem- 
radical (=f. 
branes with I-butyi hydroperoxide with and without desferrioxamine. 
Spectra were recorded at pH 7.4 and 22”C, under air-saturated condi- 
tions, 400 s after mixing. Sickle erythrocyte membranes were mixed 
with t-butyl hydroperoxide (10 mM) and DMPQ (40 mM) in the 
abseuce of desferrioxamine {A) and with 90 rM desferrioxamine (3). 
Spectra assigned to a mixture of the peroxyl {a) and alkoxyl <A) 
radical adduets to DMPO and to the ~f~~xarnine nitroxide 
associated with sickle erythrocyte membranes and by 
other systems, 
The generation of the desferrioxamine nitroxide 
radical in all of these systems indicates that desferriox- 
amine is acting as a chain breaking radical scavenger by 
donating an electron or hydrogen atom from the 
hydroxamate centre, although the possibility that 
desferrioxamine is additionally involved in chelating 
available non-haem iron associated with the sickle 
erythrocyte membrane cannot be excluded. This may 
have important implications in the development of 
possible strategies to suppress the uxidative damage in 
sickle e~~~~es. 
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